DK1499312T3 - Anvendelse af hydroxypyridonderivater til sårheling - Google Patents

Anvendelse af hydroxypyridonderivater til sårheling

Info

Publication number: DK1499312T3
Authority: DK; Denmark
Prior art keywords: wound healing; hydroxypyridone derivatives; hydroxypyridone; derivatives; wounds
Prior art date: 2002-04-20

Application number

DK03718739T

Other languages

English (en)

Inventor

Karl Theodor Kraemer

Manfred Bohn

Roland H Wenger

Original Assignee

Sanofi Aventis Deutschland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-20

Filing date

2003-04-08

Publication date

2007-07-02

2003-04-08 Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland

2007-07-02 Application granted granted Critical

2007-07-02 Publication of DK1499312T3 publication Critical patent/DK1499312T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Medicinal Preparation (AREA)

DK03718739T 2002-04-20 2003-04-08 Anvendelse af hydroxypyridonderivater til sårheling DK1499312T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP02008902A EP1354586A1 (en)	2002-04-20	2002-04-20	The use of hydroxpyridone-derivatives in wound healing
PCT/EP2003/003618 WO2003088966A1 (en)	2002-04-20	2003-04-08	The use of hydroxypyridone-derivatives in wound healing

Publications (1)

Publication Number	Publication Date
DK1499312T3 true DK1499312T3 (da)	2007-07-02

Family

ID=28459510

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03718739T DK1499312T3 (da)	2002-04-20	2003-04-08	Anvendelse af hydroxypyridonderivater til sårheling

Country Status (16)

Country	Link
US (1)	US20040014794A1 (da)
EP (2)	EP1354586A1 (da)
JP (1)	JP4709489B2 (da)
AT (1)	ATE357915T1 (da)
AU (1)	AU2003222802B2 (da)
BR (1)	BR0309403A (da)
CA (1)	CA2482972C (da)
CY (1)	CY1106472T1 (da)
DE (1)	DE60312840T2 (da)
DK (1)	DK1499312T3 (da)
ES (1)	ES2282615T3 (da)
IL (1)	IL164536A (da)
MX (1)	MXPA04009186A (da)
PT (1)	PT1499312E (da)
SI (1)	SI1499312T1 (da)
WO (1)	WO2003088966A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009044403A2 (en)	2007-10-05	2009-04-09	Juvenis Ltd.	Injectable biodegradable polymer compositions for soft tissue repair and augmentation
AU2011261499B2 (en)	2010-06-01	2015-07-16	Biotheryx, Inc.	Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases
GB201509847D0 (en)	2015-06-08	2015-07-22	Nautilus Biosciences Canada Inc	Anti-dandruff agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1322169C (en) *	1988-04-22	1993-09-14	Hiroshi Yamazaki	Ionic dressing of topical administration of drugs to wounds and burns
US5723119A (en) *	1989-07-28	1998-03-03	Schering Corporation	Method for enhancing wound healing/repair with IL-4
US5728546A (en) *	1995-06-05	1998-03-17	Human Genome Sciences, Inc.	Fibroblast growth factor 13
FR2737118B1 (fr) *	1995-07-28	1997-09-05	Oreal	Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
EP0927716B1 (en) *	1995-10-25	2003-05-07	Senju Pharmaceutical Co., Ltd.	Angiogenesis inhibitor
US5811078A (en) *	1997-03-14	1998-09-22	Adolor Corporation	Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions therewith
DE19802708A1 (de) *	1998-01-24	1999-07-29	Hoechst Marion Roussel De Gmbh	Verwendung von hydroxypyridon-haltigen Puderzubereitungen zur Behandlung von Unterschenkel- und Druckgeschwüren
US7387779B2 (en) *	1998-06-17	2008-06-17	Beth Israel Deaconess Medical Center	Anti-angiogenic proteins and fragments and methods of use thereof
SE521431C2 (sv) *	1999-12-02	2003-11-04	Sca Hygiene Prod Ab	Användning av en pH-buffrande substans för att förhindra hudinfektioner orsakade av Candida Albicans
US20030008820A1 (en) *	2001-03-27	2003-01-09	Massachusetts Institute Of Technology	Methods and products related to FGF dimerization
EP1420786A2 (en) *	2001-08-23	2004-05-26	The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services	Methods of inhibiting formation of vascular channels and proliferation using pyridinone derivatives

2002
- 2002-04-20 EP EP02008902A patent/EP1354586A1/en not_active Withdrawn
2003
- 2003-04-08 AU AU2003222802A patent/AU2003222802B2/en not_active Ceased
- 2003-04-08 BR BR0309403-0A patent/BR0309403A/pt not_active Application Discontinuation
- 2003-04-08 DE DE60312840T patent/DE60312840T2/de not_active Expired - Lifetime
- 2003-04-08 SI SI200330773T patent/SI1499312T1/sl unknown
- 2003-04-08 PT PT03718739T patent/PT1499312E/pt unknown
- 2003-04-08 ES ES03718739T patent/ES2282615T3/es not_active Expired - Lifetime
- 2003-04-08 CA CA2482972A patent/CA2482972C/en not_active Expired - Fee Related
- 2003-04-08 MX MXPA04009186A patent/MXPA04009186A/es active IP Right Grant
- 2003-04-08 DK DK03718739T patent/DK1499312T3/da active
- 2003-04-08 EP EP03718739A patent/EP1499312B1/en not_active Expired - Lifetime
- 2003-04-08 JP JP2003585718A patent/JP4709489B2/ja not_active Expired - Fee Related
- 2003-04-08 AT AT03718739T patent/ATE357915T1/de active
- 2003-04-08 WO PCT/EP2003/003618 patent/WO2003088966A1/en active IP Right Grant
- 2003-04-17 US US10/417,967 patent/US20040014794A1/en not_active Abandoned
2004
- 2004-10-12 IL IL164536A patent/IL164536A/en active IP Right Grant
2007
- 2007-05-21 CY CY20071100684T patent/CY1106472T1/el unknown

Also Published As

Publication number	Publication date
EP1499312A1 (en)	2005-01-26
IL164536A0 (en)	2005-12-18
AU2003222802A1 (en)	2003-11-03
IL164536A (en)	2011-11-30
WO2003088966A1 (en)	2003-10-30
EP1354586A1 (en)	2003-10-22
CA2482972A1 (en)	2003-10-30
DE60312840T2 (de)	2007-12-13
AU2003222802B2 (en)	2008-01-03
JP4709489B2 (ja)	2011-06-22
DE60312840D1 (de)	2007-05-10
ES2282615T3 (es)	2007-10-16
SI1499312T1 (sl)	2007-08-31
PT1499312E (pt)	2007-05-31
MXPA04009186A (es)	2004-11-26
US20040014794A1 (en)	2004-01-22
BR0309403A (pt)	2005-02-01
CY1106472T1 (el)	2012-01-25
CA2482972C (en)	2011-02-01
EP1499312B1 (en)	2007-03-28
ATE357915T1 (de)	2007-04-15
JP2005529875A (ja)	2005-10-06

Publication	Publication Date	Title
ATE453393T1 (de)	2010-01-15	Verwendung von pyridylamiden als angiogenesehemmer
CY1109886T1 (el)	2014-09-10	Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
ATE385419T1 (de)	2008-02-15	Dermatologische und kosmetische zusammensetzungen enthaltend ein furfurylderivat
IS2520B (is)	2009-07-15	Nikótínamíð afleiður nytsamlegar sem P38 hindrar
ATE371656T1 (de)	2007-09-15	Heteroaryl-pyrimidinderivate als jak-inhibitoren
ATE245152T1 (de)	2003-08-15	Dioxocyclopentylhydroxamsäure
DE60315146D1 (de)	2007-09-06	Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
ATE302775T1 (de)	2005-09-15	Carbolinderivate
DE50310516D1 (de)	2008-10-30	Fredericamycin-derivate
ATE307810T1 (de)	2005-11-15	Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
DE60324544D1 (de)	2008-12-18	Muskarin antagonisten
DE60121461D1 (de)	2006-08-24	Kondensierte pyridoindolderivate
SE0400043D0 (sv)	2004-01-12	New compounds
PE20030061A1 (es)	2003-02-08	1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
NO20043016L (no)	2004-07-15	6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
ATE311389T1 (de)	2005-12-15	Wirkstoffvorläufer von imidazopyridin-derivaten
ATE359283T1 (de)	2007-05-15	Substituierte pyrazinonverbindungen zur behandlung von entzündungen
NO20054361D0 (no)	2005-09-20	Benzensylfonamidderivater, fremgangsmate for fremstilling og anvendelse derav for behandlig av smerte
ATE419242T1 (de)	2009-01-15	Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
DE60131968D1 (de)	2008-01-31	PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
DK1499312T3 (da)	2007-07-02	Anvendelse af hydroxypyridonderivater til sårheling
DK1441726T3 (da)	2007-04-10	Derivater af phenoxy-N' -4-(isothiazolidin-1,1-dioxid-2-yl)phenyl]-valerianesyreamid og andre forbindelser som inhibitorer af koagulationsfaktoren Xa til behandling af thromboemboliske lidelser og tumorer
ATE276259T1 (de)	2004-10-15	Dihydroporphyrinderivate und ihre verwendung
DE60013515D1 (de)	2004-10-14	4-Arylpiperidinderivate zur Behandlung von Pruritus
ATE334977T1 (de)	2006-08-15	Discodermolid-analoga und ihre pharmazeutische verwendung